title: New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation.
authors.forename: Saulius
authors.initials: S
authors.lastname: Girnius
authors.forename: David C
authors.initials: DC
authors.lastname: Seldin
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Cibeira
authors.forename: Vaishali
authors.initials: V
authors.lastname: Sanchorawala
mesh_terms: D000686:Amyloidosis / Q000097:blood* / Q000628:therapy*; D005260:Female; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood*; D008297:Male
chemical_list: D007147:Immunoglobulin Light Chains